Revision history of "DEVELOPMENT OF A BIOCOMPATIBLE PRODUCT FOR FICILI_2790 INJURY THERAPY" (Q2310940)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 07:3507:35, 9 October 2024DG Regio talk contribs 47,318 bytes +4 Changed label, description and/or aliases in pt
  • curprev 07:3507:35, 9 October 2024DG Regio talk contribs 47,314 bytes +15 Set a claim value: summary (P836): O PRESENTE PROJECTO REFERE-SE AO DESENVOLVIMENTO E AOS MODELOS IN VITRO E IN VIVO EM MODELOS PRÉ-CLINICOS DE UM PRODUTO TERAPÊUTICO INOVADO, BASEADO NA COMBINAÇÃO DE TRÊS ELEMENTOS (MATRIZ EXTRACELLULAR, CÉLULAS ENDOTELIAIS E CONDUTORES DE CRESCIMENTO), UTILIZANDO O BIOREACTOR AUTOMÁTICO NANT 001 PARA PERMITIR A NORMALIZAÇÃO DO PROCESSO, A VIGILÂNCIA DO TEMPO E O CUSTO DO PROCESSO DE CÉLULAS ENDOTELIAIS AUTOMÁTICAS (ISOLIGADAS POR UM BIOPAENTE NO ME...

7 March 2024

26 April 2023

8 April 2023

16 August 2022

  • curprev 20:0620:06, 16 August 2022DG Regio talk contribs 44,616 bytes +28,670 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

3 February 2022

26 January 2022

6 January 2022

25 December 2021

24 December 2021

4 November 2020

16 September 2020

8 June 2020

24 March 2020

23 March 2020

  • curprev 10:5510:55, 23 March 2020DG Regio talk contribs 8,792 bytes +839 Created claim: summary (P836): THIS PROJECT CONCERNS THE DEVELOPMENT AND THE IN VITRO AND IN VIVO MODELS IN PRE-CLINICAL MODELS OF AN INNOVATIVE THERAPEUTIC PRODUCT BASED ON THE COMBINATION OF THREE ELEMENTS (EXTRACELLULAR MATRIX, ENDOTHELIAL CELLS AND GROWTH DRIVERS), USING THE AUTOMATIC NANT 001 BIOREACTOR IN ORDER TO ALLOW STANDARDISATION OF THE PROCESS, AVOIDANCE OF TIME AND COST OF THE PROCESS OF AUTOLOGOUS ENDOTHELIAL CELLS (ISOLATED BY A PATIENT BIOPSY IN THE SAME PATI...

17 March 2020

13 March 2020